Watch Ticker

Zevra Therapeutics, Inc. Common Stock

Go to Zevra Therapeutics, Inc. Common Stock Website

$11.37

0.12 (1.07%)

Live

Previous Close

$11.25

Day Range

$11.16 - $11.44

Previous Day Range

$10.9 - $11.34

Market Cap

$607.5 million USD

Day Vol.

635775

Previous Day Vol.

582480

Currency

USD

Primary Exchange

Nasdaq

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Globe Newswire - Zevra Therapeutics Enters Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million

Zevra Therapeutics has entered into an agreement to sell its Rare Pediatric Disease Priority Review Voucher for $150 million, strengthening its balance sheet and supporting its strategic priorities.

Related tickers: ZVRA.

Read Full Article

N/A - Zevra Therapeutics Announces Organizational Changes

Zevra Therapeutics is consolidating its development and scientific functions under the Chief Medical Officer, resulting in the departure of the Chief Development Officer and Chief Scientific Officer. The company is also discontinuing its in-house drug discovery activities and closing its laboratory facilities to focus on late-stage clinical development and commercial opportunities.

Related tickers: ZVRA.

Read Full Article

Trending Tickers

Please sign in to view